Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
Condition: Stage III Non-small-cell Lung Cancer Interventions: Other: Neoadjuvant therapy; Other: Chemotherapy concurrent with radiotherapy; Radiation: Radiotherapy; Drug: Nivolumab; Other: Observation Sponsor: Sun Yat-sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials